{"id":"F2022L00277","name":"Statement of Principles concerning heart block (Balance of Probabilities) (No. 24 of 2022)","slug":"statement-of-principles-concerning-heart-block-balance-of-probabilities-no-24-of-2022","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"in_force","isInForce":true,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":441258,"registerId":"F2022L00277-fast-fetch-1775956617204","compilationNumber":null,"startDate":"2026-04-12","status":"InForce","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Statement of Principles concerning heart block (Balance of Probabilities) (No. 24 of 2022)","content":"---\nmeta-content-style-type: text/css\nmeta-content-type: application/xhtml+xml; charset=utf-8\nmeta-generator: Aspose.Words for .NET 20.2\n---\n\n?xml version=\"1.0\" encoding=\"utf-8\" standalone=\"no\"?>\n\n\n\n \n\nStatement of Principles\n\nconcerning\n\nHEART BLOCK (Balance of Probabilities)\n\n(No. 24 of 2022)\n\nThe Repatriation Medical Authority determines the following Statement of Principles under subsection 196B(3) of the Veterans' Entitlements Act 1986.\n\n \n\nDated 4 March 2022\n\n \n\n \n\n \n\n \n\n \n\n| The Common Seal of the Repatriation Medical Authority was affixed to this instrument at the direction of:
|\n| --- |\n|
Professor Terence Campbell AM
Chairperson
|\n\n\n \n\n \n\n\nContents\n\n1 Name\n\n2 Commencement\n\n3 Authority\n\n4 Repeal\n\n5 Application\n\n6 Definitions\n\n7 Kind of injury, disease or death to which this Statement of Principles relates\n\n8 Basis for determining the factors\n\n9 Factors that must exist\n\n10 Relationship to service\n\n11 Factors referring to an injury or disease covered by another Statement of Principles\n\nSchedule 1 - Dictionary\n\n1 Definitions\n\n \n\n\n\n\n1 Name\n\nThis is the Statement of Principles concerning heart block (Balance of Probabilities) (No. 24 of 2022).\n\n2 Commencement\n\n This instrument commences on 4 April 2022.\n\n3 Authority\n\nThis instrument is made under subsection 196B(3) of the Veterans' Entitlements Act 1986.\n\n4 Repeal\n\nThe Statement of Principles concerning heart block No. 2 of 2014 (Federal Register of Legislation No. F2014L00005) made under subsections 196B(3) and (8) of the VEA is repealed.\n\n5 Application\n\nThis instrument applies to a claim to which section 120B of the VEA or section 339 of the Military Rehabilitation and Compensation Act 2004 applies.\n\n6 Definitions\n\nThe terms defined in the Schedule 1 - Dictionary have the meaning given when used in this instrument.\n\n7 Kind of injury, disease or death to which this Statement of Principles relates\n\n(1) This Statement of Principles is about heart block and death from heart block.\n\nMeaning of heart block\n\n(2) For the purposes of this Statement of Principles, heart block:\n\n(a) means a cardiac disorder in which there is a delay or interruption to the conduction of electrical impulse from the atria to the ventricles through the atrioventricular node, bundle of His or the bundle branches due to an anatomical or functional impairment in the conduction system; and\n\n(b) includes atrioventricular block and bundle branch block; and\n\n(c) excludes congenital heart block, long QT syndrome and transient physiological heart block.\n\nNote 1: Heart block includes right and left bundle branch block, bifascicular and trifascicular block, and first, second and third degree atrioventricular block.\n\nNote 2: Second degree heart block includes Mobitz type I (Wenckebach) and Mobitz type II atrioventricular block.\n\nNote 3: Heart block may be asymptomatic in some cases. Symptoms of heart block typically include fatigue, shortness of breath or chest pain on exertion, dizziness and fainting (syncope).\n\n(3) While heart block attracts ICD‑10‑AM code I44, I45.0, I45.1, I45.2, I45.3, I45.4 or I45.9, in applying this Statement of Principles the meaning of heart block is that given in subsection (2).\n\n(4) For subsection (3), a reference to an ICD-10-AM code is a reference to the code assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM), Tenth Edition, effective date of 1 July 2017, copyrighted by the Independent Hospital Pricing Authority, ISBN 978-1-76007-296-4.\n\nDeath from heart block\n\n(5) For the purposes of this Statement of Principles, heart block, in relation to a person, includes death from a terminal event or condition that was contributed to by the person's heart block.\n\nNote: terminal event is defined in the Schedule 1 - Dictionary.\n\n8 Basis for determining the factors\n\nOn the sound medical‑scientific evidence available, the Repatriation Medical Authority is of the view that it is more probable than not that heart block and death from heart block can be related to relevant service rendered by veterans or members of the Forces under the VEA, or members under the MRCA.\n\nNote: MRCA, relevant service and VEA are defined in the Schedule 1 - Dictionary.\n\n9 Factors that must exist\n\nAt least one of the following factors must exist before it can be said that, on the balance of probabilities, heart block or death from heart block is connected with the circumstances of a person's relevant service:\n\n(1) having ischaemic heart disease at the time of the clinical onset of heart block;\n\n(2) having pulmonary thromboembolism within the 7 days before the clinical onset of heart block;\n\n(3) having infiltration of the myocardium due to amyloidosis or sarcoidosis at the time of the clinical onset of heart block;\n\n(4) having cardiomyopathy at the time of the clinical onset of heart block;\n\n(5) having a benign or malignant neoplasm involving the heart before the clinical onset of heart block;\n\nNote: A neoplasm involving the heart can be primary or metastatic. An example of a primary neoplasm involving the heart is cardiac lymphoma.\n\n(6) having a lesion which compresses the atrioventricular node, bundle of His or the bundle branches of the heart at the time of the clinical onset of heart block;\n\nNote: Examples of lesions which can compress the atrioventricular node, bundle of His or the bundle branches of the heart include a paraoeseophageal hiatus hernia, a thoracic aortic aneurysm and a haematoma.\n\n(7) having non-infectious myocarditis at the time of the clinical onset of heart block;\n\nNote 1: Non-infectious myocarditis can be acute or chronic.\n\nNote 2: Non-infectious myocarditis can be of autoimmune, infiltrative or immunological origin. Examples of causes of non-infectious myocarditis include immune checkpoint inhibitor therapy and giant cell myocarditis.\n\n(8) having viral myocarditis at the time of the clinical onset of heart block;\n\nNote 1: Viral myocarditis can be acute or chronic.\n\nNote 2: Examples of viral causes of myocarditis include severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), human immunodeficiency virus, group B coxsackieviruses and dengue virus.\n\n(9) having a non-viral infection of the myocardium at the time of the clinical onset of heart block;\n\nNote 1: A non-viral infection of the myocardium can be caused by bacteria, protozoa, fungi or parasites.\n\nNote 2: Examples of non-viral infections of the myocardium include:\n\n(a) Borrelia burgdorferi (Lyme disease);\n\n(b) Corynebacterium diphtheriae (diphtheria);\n\n(c) Cysticercus species (cysticercosis);\n\n(d) Echinococcus species (hydatid disease);\n\n(e) Treponema pallidum (tertiary syphilis);\n\n(f) Trypanosoma cruzi (Chagas disease); and\n\n(g) Toxoplasma gondii (toxoplasmosis).\n\n(10) having infective endocarditis at the time of the clinical onset of heart block;\n\n(11) having a mineral or electrolyte abnormality from the specified list of mineral or electrolyte abnormalities at the time of the clinical onset of heart block;\n\nNote: specified list of mineral or electrolyte abnormalities is defined in the Schedule 1 - Dictionary.\n\n(12) taking a drug from the specified list of drugs within the 3 weeks before the clinical onset of heart block;\n\nNote: specified list of drugs is defined in the Schedule 1 - Dictionary.\n\n(13) taking chloroquine or hydroxychloroquine for at least 1 year before the clinical onset of heart block;\n\n(14) having ingested a plant containing cardiac glycosides within the 7 days before the clinical onset of heart block;\n\nNote: Examples of plants containing cardiac glycosides include the pong-pong tree (Cerbera odollam) and foxglove (Digitalis purpurea).\n\n(15) experiencing penetrating trauma to the heart within the 1 year before the clinical onset of heart block;\n\n(16) having a thoracic surgical procedure or an invasive cardiac procedure within the 1 year before the clinical onset of heart block;\n\nNote 1: Examples of thoracic surgical procedures include vascular, mediastinal, pulmonary and chest wall surgery.\n\nNote 2: Examples of invasive cardiac procedures include:\n\n(a) alcohol septal ablation;\n\n(b) catheter ablation of arrhythmias;\n\n(c) open heart surgery; and\n\n(d) transcatheter aortic valve implantation.\n\n(17) experiencing a blunt chest injury within the 60 days before the clinical onset of heart block;\n\nNote: blunt chest injury is defined in the Schedule 1 - Dictionary.\n\n(18) having a heart transplant before the clinical onset of heart block;\n\n(19) having a bone marrow transplant or stem cell transplant within the 24 hours before the clinical onset of heart block;\n\n(20) having graft versus host disease after a bone marrow transplant or stem cell transplant at the time of the clinical onset of heart block;\n\n(21) undergoing a course of therapeutic radiation for cancer, where the heart was in the field of radiation, before the clinical onset of heart block;\n\n(22) undertaking strenuous physical activity greater than 6 METs for an average of at least 10 hours per week for a continuous period of at least the 5 years before the clinical onset of heart block;\n\nNote: MET is defined in the Schedule 1 - Dictionary.\n\n(23) having diabetes mellitus at the time of the clinical onset of heart block;\n\n(24) having hypertension with left ventricular hypertrophy before the clinical onset of heart block;\n\n(25) having an autoimmune disease from the specified list of autoimmune diseases at the time of the clinical onset of heart block;\n\nNote: specified list of autoimmune diseases is defined in the Schedule 1 - Dictionary.\n\n(26) having acute rheumatic fever at the time of the clinical onset of heart block;\n\n(27) having rheumatic heart disease at the time of the clinical onset of heart block;\n\n(28) having ischaemic heart disease at the time of the clinical worsening of heart block;\n\n(29) having pulmonary thromboembolism within the 7 days before the clinical worsening of heart block;\n\n(30) having infiltration of the myocardium due to amyloidosis or sarcoidosis at the time of the clinical worsening of heart block;\n\n(31) having cardiomyopathy at the time of the clinical worsening of heart block;\n\n(32) having a benign or malignant neoplasm involving the heart before the clinical worsening of heart block;\n\nNote: A neoplasm involving the heart can be primary or metastatic. An example of a primary neoplasm involving the heart is cardiac lymphoma.\n\n(33) having a lesion which compresses the atrioventricular node, bundle of His or the bundle branches of the heart at the time of the clinical worsening of heart block;\n\nNote: Examples of lesions which can compress the atrioventricular node, bundle of His or the bundle branches of the heart include a paraoeseophageal hiatus hernia, a thoracic aortic aneurysm and a haematoma.\n\n(34) having non-infectious myocarditis at the time of the clinical worsening of heart block;\n\nNote 1: Non-infectious myocarditis can be acute or chronic.\n\nNote 2: Non-infectious myocarditis can be of autoimmune, infiltrative or immunological origin. Examples of causes of non-infectious myocarditis include immune checkpoint inhibitor therapy and giant cell myocarditis.\n\n(35) having viral myocarditis at the time of the clinical worsening of heart block;\n\nNote 1: Viral myocarditis can be acute or chronic.\n\nNote 2: Examples of viral causes of myocarditis include severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), human immunodeficiency virus, group B coxsackieviruses and dengue virus.\n\n(36) having a non-viral infection of the myocardium at the time of the clinical worsening of heart block;\n\nNote 1: A non-viral infection of the myocardium can be caused by bacteria, protozoa, fungi or parasites.\n\nNote 2: Examples of non-viral infections of the myocardium include:\n\n(a) Borrelia burgdorferi (Lyme disease);\n\n(b) Corynebacterium diphtheriae (diphtheria);\n\n(c) Cysticercus species (cysticercosis);\n\n(d) Echinococcus species (hydatid disease);\n\n(e) Treponema pallidum (tertiary syphilis);\n\n(f) Trypanosoma cruzi (Chagas disease); and\n\n(g) Toxoplasma gondii (toxoplasmosis).\n\n(37) having infective endocarditis at the time of the clinical worsening of heart block;\n\n(38) having a mineral or electrolyte abnormality from the specified list of mineral or electrolyte abnormalities at the time of the clinical worsening of heart block;\n\nNote: Note: specified list of mineral or electrolyte abnormalities is defined in the Schedule 1 - Dictionary.\n\n(39) taking a drug from the specified list of drugs within the 3 weeks before the clinical worsening of heart block;\n\nNote: specified list of drugs is defined in the Schedule 1 - Dictionary.\n\n(40) taking chloroquine or hydroxychloroquine for at least 1 year before the clinical worsening of heart block;\n\n(41) having ingested a plant containing cardiac glycosides within the 7 days before the clinical worsening of heart block;\n\nNote: Examples of plants containing cardiac glycosides include the pong-pong tree (Cerbera odollam) and foxglove (Digitalis purpurea).\n\n(42) experiencing penetrating trauma to the heart within the 1 year before the clinical worsening of heart block;\n\n(43) having a thoracic surgical procedure or an invasive cardiac procedure within the 1 year before the clinical worsening of heart block;\n\nNote 1: Examples of thoracic surgical procedures include vascular, mediastinal, pulmonary and chest wall surgery.\n\nNote 2: Examples of invasive cardiac procedures include:\n\n(a) alcohol septal ablation;\n\n(b) catheter ablation of arrhythmias;\n\n(c) open heart surgery; and\n\n(d) transcatheter aortic valve implantation.\n\n(44) experiencing a blunt chest injury within the 60 days before the clinical worsening of heart block;\n\nNote: blunt chest injury is defined in the Schedule 1 - Dictionary.\n\n(45) having a heart transplant before the clinical worsening of heart block;\n\n(46) having a bone marrow transplant or stem cell transplant within the 24 hours before the clinical worsening of heart block;\n\n(47) having graft versus host disease after a bone marrow transplant or stem cell transplant at the time of the clinical worsening of heart block;\n\n(48) undergoing a course of therapeutic radiation for cancer, where the heart was in the field of radiation, before the clinical worsening of heart block;\n\n(49) undertaking strenuous physical activity greater than 6 METs for an average of at least 10 hours per week for a continuous period of at least the 5 years before the clinical worsening of heart block;\n\nNote: MET is defined in the Schedule 1 - Dictionary.\n\n(50) having diabetes mellitus at the time of the clinical worsening of heart block;\n\n(51) having hypertension with left ventricular hypertrophy before the clinical worsening of heart block;\n\n(52) having an autoimmune disease from the specified list of autoimmune diseases at the time of the clinical worsening of heart block;\n\nNote: specified list of autoimmune diseases is defined in the Schedule 1 - Dictionary.\n\n(53) having acute rheumatic fever at the time of the clinical worsening of heart block;\n\n(54) having rheumatic heart disease at the time of the clinical worsening of heart block;\n\n(55) inability to obtain appropriate clinical management for heart block.\n\n10 Relationship to service\n\n(1) The existence in a person of any factor referred to in section 9, must be related to the relevant service rendered by the person.\n\n(2) The factors set out in subsections 9(28) to 9(55) apply only to material contribution to, or aggravation of, heart block where the person's heart block was suffered or contracted before or during (but did not arise out of) the person's relevant service.\n\n11 Factors referring to an injury or disease covered by another Statement of Principles\n\nIn this Statement of Principles:\n\n(1) if a factor referred to in section 9 applies in relation to a person; and\n\n(2) that factor refers to an injury or disease in respect of which a Statement of Principles has been determined under subsection 196B(3) of the VEA;\n\nthen the factors in that Statement of Principles apply in accordance with the terms of that Statement of Principles as in force from time to time.\n\n \n\n \n\nSchedule 1 - Dictionary \n\nNote: See Section 6\n\n1 Definitions\n\nIn this instrument:\n\n blunt chest injury means a non-penetrating blow to the chest.\n\nNote: Examples of causes of blunt chest injury include a motor vehicle accident, a direct blow to the chest wall by airbag deployment, impact in contact sports, a fall from a height, a crush injury and being struck by a projectile.\n\n heart block—see subsection 7(2).\n\n MET means a unit of measurement of the level of physical exertion. 1 MET = 3.5 ml of oxygen/kg of body weight per minute, or 1.0 kcal/kg of body weight per hour, or resting metabolic rate.\n\n MRCA means the Military Rehabilitation and Compensation Act 2004.\n\n relevant service means:\n\n(a) eligible war service (other than operational service) under the VEA;\n\n(b) defence service (other than hazardous service and British nuclear test defence service) under the VEA; or\n\n(c) peacetime service under the MRCA.\n\nNote: MRCA and VEA are also defined in the Schedule 1 - Dictionary.\n\n specified list of autoimmune diseases means:\n\n(a) ankylosing spondylitis;\n\n(b) granulomatosis with polyangiitis (Wegener granulomatosis);\n\n(c) rheumatoid arthritis; \n\n(d) Sjögren syndrome;\n\n(e) systemic lupus erythematosus; or\n\n(f) systemic sclerosis (scleroderma).\n\n specified list of drugs means:\n\n(a) acetylcholinesterase inhibitors including donepezil, galantamine, neostigmine and rivastigmine;\n\n(b) anthracycline chemotherapeutic agents including doxorubicin and daunorubicin;\n\n(c) beta blockers; \n\n(d) carbamazepine;\n\n(e) cardiac glycosides including digoxin;\n\n(f) chloroquine or hydroxychloroquine;\n\n(g) class 1A, class 1C or class III anti-arrhythmic agents including procainamide, flecainide and amiodarone;\n\n(h) immune checkpoint inhibitors;\n\n(i) lacosamide;\n\n(j) lithium;\n\n(k) mefloquine;\n\n(l) non-dihydropyridine calcium channel blockers including diltiazem and verapamil;\n\n(m) paclitaxel;\n\n(n) quinine;\n\n(o) trastuzumab; or\n\n(p) trazodone.\n\n specified list of mineral or electrolyte abnormalities means:\n\n(a) hypercalcaemia; \n\n(b) hyperkalaemia; or\n\n(c) hypermagnesaemia.\n\n terminal event means the proximate or ultimate cause of death and includes the following:\n\n(a) pneumonia;\n\n(b) respiratory failure;\n\n(c) cardiac arrest;\n\n(d) circulatory failure; or\n\n(e) cessation of brain function.\n\n VEA means the Veterans' Entitlements Act 1986.\n\n \n\n \n","sortOrder":0}],"analysis":{"flash_summary":{"complexity_score":4,"scope_assessment":{"changed":true,"description":"Section 4 repeals the 2014 Statement of Principles and replaces it with updated criteria. The new instrument (applies to VEA and MRCA claims per section 5) expands and clarifies the listed causal factors and timeframes in section 9 (for both clinical onset and clinical worsening), adds explicit drug, autoimmune and electrolyte lists (Schedule 1), and includes an inability to obtain appropriate clinical management as a factor; relationship‑to‑service limits are set out in section 10."},"complexity_factors":["Extensive medical and technical terminology (cardiac conduction system, myocarditis, cardiomyopathy, etc.).","Long enumerated list of causal factors with varied time windows and dual sets for clinical onset and clinical worsening (section 9).","Multiple specified lists (drugs, autoimmune diseases, mineral/electrolyte abnormalities) that require clinical verification (Schedule 1).","Cross‑references to other Statements of Principles where overlapping conditions apply (section 11).","Service‑relationship rules restricting some factors to contribution or aggravation when pre‑existing (section 10).","Repeal and replacement of an earlier instrument, requiring comparison to prior criteria for claimants and advisers (section 4)."],"plain_english_summary":"**This instrument sets the medical criteria used to decide, on the balance of probabilities, whether heart block (including death from it) is connected to a veteran's relevant service for claims under the VEA and MRCA.** It lists specific medical conditions, infections, procedures, drugs, exposures and time‑limits that, if present, make such a service connection more probable; the Repatriation Medical Authority adopted these on available medical‑scientific evidence."},"flash_summary_failed":{"failed":true,"reason":"Unauthenticated. Configure AI_GATEWAY_API_KEY or use a provider module. Learn more: https://ai-sdk.dev/unauthenticated-ai-gateway","source":"analysis-cron"},"kimi_summary":{"content_quality":"ok","complexity_score":6,"scope_assessment":{"changed":false,"description":"This is a standard replacement Statement of Principles maintaining the established framework under section 196B(3) of the VEA. The scope remains consistent with the original legislative intent: providing medical criteria for determining service connection of specific conditions. The 2022 update reflects new medical evidence (including SARS-CoV-2 as a viral cause) but does not expand beyond the established purpose of defining causal factors for compensation purposes."},"complexity_factors":["55 distinct factors with specific temporal requirements (ranging from 24 hours to 5 years before onset/worsening)","Parallel structure with factors 1-27 covering 'clinical onset' and factors 28-54 covering 'clinical worsening', creating near-duplicative content","Multiple defined terms requiring cross-reference to Schedule 1 (7 explicit definitions plus 3 compound defined terms: 'specified list of autoimmune diseases', 'specified list of drugs', 'specified list of mineral or electrolyte abnormalities')","Nested definitional dependencies — factors reference other Statements of Principles (section 11), creating external cross-referencing obligations","Technical medical terminology throughout (e.g., 'atrioventricular node', 'bundle of His', 'bifascicular and trifascicular block', 'METs')","Conditional logic in section 10(2) restricting factors 28-55 to aggravation cases only (where condition pre-existed service)","ICD-10-AM coding reference with specific edition citation (Tenth Edition, 1 July 2017)","Dual statutory framework application (VEA and MRCA with different service definitions)"],"plain_english_summary":"Updates the 2014 medical rules for linking heart block to military service, listing 55 specific medical factors and using the \"balance of probabilities\" test to decide entitlement. It affects veterans and current/former defence members claiming under the VEA 1986 or MRCA 2004.\n\nThe checklist covers prior heart disease, infections, certain medications, chest injury/heart surgery, long-term strenuous activity, cardiac radiation, and lack of treatment. If heart block and at least one listed factor relate to service, claimants may get compensation or treatment."}},"importantCases":[],"_links":{"self":"/api/acts/statement-of-principles-concerning-heart-block-balance-of-probabilities-no-24-of-2022","history":"/api/acts/statement-of-principles-concerning-heart-block-balance-of-probabilities-no-24-of-2022/history","analysis":"/api/acts/statement-of-principles-concerning-heart-block-balance-of-probabilities-no-24-of-2022/analysis","conflicts":"/api/acts/statement-of-principles-concerning-heart-block-balance-of-probabilities-no-24-of-2022/conflicts","importantCases":"/api/acts/statement-of-principles-concerning-heart-block-balance-of-probabilities-no-24-of-2022/important-cases","documents":"/api/acts/statement-of-principles-concerning-heart-block-balance-of-probabilities-no-24-of-2022/documents"}}